Core Viewpoint - Qingdao Guoen Technology Co., Ltd. has officially submitted its listing application to the Hong Kong Stock Exchange, marking a significant step in its capital market strategy and aiming to enhance its international influence and competitiveness [1] Group 1: Company Overview - Guoen Technology is a comprehensive enterprise group driven by technological innovation, focusing on long-term scale efficiency and implementing a "one body, two wings" development strategy in the large chemical and health industries [2] - In the large chemical sector, Guoen Technology is the second-largest organic polymer material modification producer in China and the largest producer of polystyrene, showcasing its strong market position [2] - In the health industry, Guoen Technology's subsidiary Dongbao Biological has established a comprehensive product layout from collagen to "collagen +", becoming a significant player in the health sector [3] Group 2: Financial Performance - The company has shown strong revenue growth, with total revenues of approximately RMB 134.06 billion, RMB 174.39 billion, and RMB 191.88 billion for the fiscal years 2022, 2023, and 2024, respectively [4] - The main revenue source is the large chemical sector, contributing RMB 183.3 billion in 2024, accounting for 95.6% of total revenue, while the health sector contributed RMB 8.53 billion, representing 4.4% of total revenue [5] - The overall gross profit margins for the fiscal years 2022, 2023, and 2024 were 11.8%, 9.2%, and 8.3%, respectively, with the health sector showing a higher margin of 23.2% in 2024 [6] Group 3: Future Prospects - The successful listing on the Hong Kong Stock Exchange is expected to provide new development opportunities for the company, allowing it to expand capacity, increase R&D investment, and enhance its domestic and international market presence [6] - The company's strong foundation in the large chemical and health sectors, along with its financial performance and future growth potential, positions it as a noteworthy investment opportunity [7]

Core Viewpoint - Guoen Technology is a comprehensive enterprise group driven by technological innovation, focusing on long-term scale efficiency and implementing a "one body, two wings" development strategy in the large chemical and health industries [2]. Group 1: Industry Overview - In the large chemical industry, Guoen Technology is deeply engaged in the chemical new materials industry chain, building a "new materials+" ecosystem and enhancing its vertical integration layout [2]. - The company is the second-largest organic polymer material modification producer in China by revenue in 2024 and the largest producer of polystyrene by capacity [2]. - In the health industry, Guoen Technology focuses on the natural collagen industry, establishing a vertically integrated product layout from animal collagen to end products [2][3]. Group 2: Financial Performance - For the fiscal years 2022, 2023, and 2024, Guoen Technology reported total revenues of approximately RMB 13.406 billion, RMB 17.438 billion, and RMB 19.188 billion respectively [3][5]. - The net profit for the same periods was approximately RMB 724 million, RMB 540 million, and RMB 721 million respectively [3][5]. - The gross profit figures for the fiscal years were RMB 1.580 billion, RMB 1.601 billion, and RMB 1.592 billion respectively, indicating a stable gross profit margin [5].

鲁网4月28日讯（记者 王玉龙）4月27日上午，潍坊市非遗食药同源食品首次出口新西兰启运仪式举 行，两集装箱由黄元御（潍坊）生物科技有限公司生产的黑芝麻丸等产品将通过陆路、海路，发往新西 兰。这标志着潍坊在农业对外开放领域再添新成果。 去年以来，潍坊国家农综区推进办、潍坊海关等共同促成密州酒业清香型白酒首次出口韩国、阳春啤酒 首次出口古巴、惠发鸡肉首次出口尼日利亚、广华肉类预制菜首次出口朝鲜、圣沣烤鸭首次出口乌兹别 克斯坦、京琪鲜食葡萄首次出口新加坡等，今年又实现山东骨明胶产品首次出口土耳其，首次在全国实 施葡萄糖出口"批次检验"业务，为外贸保稳提质作出了积极贡献。 潍坊国家农综区作为全国首个农业对外开放综合试验区，始终以制度创新为核心竞争力。此次食药同源 食品顺利出口，得益于农综区与海关联合推出的通关便利化措施。近年来，潍坊国家农综区优化实施45 条支持政策，设立种质资源进口、鲜活农产品"绿色通道"，推行出口食品"即报即放"、鲜活农产品"即 验即放"等创新举措，将进出口业务办理时间从10个工作日压缩至最快2小时，企业成本降低30%；推动 山东匠造检测有限公司与新日本检定协会签约，首次实现中日农食产品检验检测 ...